Germline Predisposition to Hematolymphoid Neoplasia.

Area of Science:

• Hematopathology
• Oncology
• Genetics

Background:

• Germline predisposition to hematolymphoid neoplasms is a recognized clinical entity.
• Understanding these predispositions is crucial for accurate diagnosis and management.

Purpose of the Study:

• To review and establish consensus diagnoses for clinical cases with germline predisposition to hematolymphoid neoplasms.
• To analyze the spectrum of mutations and associated diagnoses presented at the 2017 Society for Hematopathology/European Association for Haematopathology Workshop.

Main Methods:

• Review of 51 clinical cases with confirmed germline mutations.
• Consensus diagnosis by a Workshop Panel.
• Presentation of six selected cases at the meeting.

Main Results:

• The most frequent germline mutations identified were in GATA2 (16 cases) and RUNX1 (10 cases).
• Common diagnoses included acute myeloid leukemia (15 cases) and myelodysplastic syndrome (MDS, 14 cases).
• Myeloid neoplasms associated with GATA2 and RUNX1 germline mutations were predominant.

Conclusions:

• Germline predisposition mutations, particularly in GATA2 and RUNX1, are frequently observed in hematolymphoid neoplasms.
• A germline mutation alone is insufficient for neoplasm diagnosis; standard diagnostic criteria for hematolymphoid malignancy must be met.
• Diagnostic criteria for neoplasms with germline predisposition are generally consistent with those for sporadic cases.